Beta
Repaglinide
medication Under reviewAn oral meglitinide medication used to lower blood glucose levels in individuals with type 2 diabetes by stimulating insulin release.
Research summary
Scientific evidence from pharmacokinetic studies in healthy human subjects demonstrates that repaglinide is rapidly absorbed and eliminated following oral or intravenous administration, with consistent bioavailability across tablet and solution forms. These studies highlight low intrasubject variability in key parameters like area under the curve and maximum concentration, though variability in time to peak is higher with tablets. No studies in healthy humans directly assess therapeutic benefits like glucose control or long-term health outcomes, as research focuses on patients with diabetes; thus, consensus on benefits for healthy individuals is lacking.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!